BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

被引：0
|
作者：
Beata Biesaga
Joanna Niemiec
Marek Ziobro
机构：
[1] Centre of Oncology,Department of Applied Radiobiology
[2] Centre of Oncology,Department of Medical Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2014年 / 140卷
关键词：
Early breast cancer patients; Anthracyclines; Potential prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2019
页数：10
相关论文
共 50 条
  • [1] BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy
    Biesaga, Beata
    Niemiec, Joanna
    Ziobro, Marek
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (12) : 2009 - 2019
  • [2] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Vargas-Roig, L. M.
    Cuello-Carrion, F. D.
    Fernandez-Escobar, N.
    Daguerre, P.
    Leuzzi, M.
    Ibarra, J.
    Gago, F. E.
    Nadin, S. B.
    Ciocca, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Anthracycline-based adjuvant chemotherapy in breast cancer
    Gray, Richard
    LANCET, 2010, 375 (9729): : 1870 - 1871
  • [4] Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer
    Andre, F
    Khalil, A
    Slimane, K
    Massard, C
    Mathieu, MC
    Vignot, S
    Assi, H
    Delaloge, S
    Spielmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2996 - 3000
  • [5] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Marcella Mottolese
    Maria Benevolo
    Girolamo Del Monte
    Simonetta Buglioni
    Paola Papaldo
    Cecilia Nisticò
    Franco Di Filippo
    Stefania Vasselli
    Patrizia Vici
    Claudio Botti
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 722 - 729
  • [6] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Mottolese, M
    Benevolo, M
    Del Monte, G
    Buglioni, S
    Papaldo, P
    Nisticò, C
    Di Filippo, F
    Vasselli, S
    Vici, P
    Botti, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (12) : 722 - 729
  • [7] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Clinical features and prognostic values of C-ERBB2 and topoisomerase II expression for adjuvant anthracycline-based chemotherapy in breast cancer
    Lim, K.
    Lee, H.
    Kim, T.
    Bang, Y.
    Park, I.
    HISTOPATHOLOGY, 2008, 53 : 48 - 49
  • [9] Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
    Bertucci, Francois
    Borie, Nathalie
    Roche, Henri
    Bachelot, Thomas
    Le Doussal, Jean-Marc
    Macgrogan, Gaetan
    Debono, Stephane
    Martinec, Agnes
    Treilleux, Isabelle
    Finetti, Pascal
    Esterni, Benjamin
    Extra, Jean-Marc
    Geneve, Jean
    Hermitte, Fabienne
    Chabannon, Christian
    Jacquemier, Jocelyne
    Martin, Anne-Laure
    Longy, Michel
    Maraninchi, Dominique
    Fert, Vincent
    Birnbaum, Daniel
    Viens, Patrice
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 363 - 373
  • [10] Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
    François Bertucci
    Nathalie Borie
    Henri Roche
    Thomas Bachelot
    Jean-Marc Le Doussal
    Gaëtan Macgrogan
    Stéphane Debono
    Agnès Martinec
    Isabelle Treilleux
    Pascal Finetti
    Benjamin Esterni
    Jean-Marc Extra
    Jean Geneve
    Fabienne Hermitte
    Christian Chabannon
    Jocelyne Jacquemier
    Anne-Laure Martin
    Michel Longy
    Dominique Maraninchi
    Vincent Fert
    Daniel Birnbaum
    Patrice Viens
    Breast Cancer Research and Treatment, 2011, 127 : 363 - 373
12345